BiochemistrybioRxiv
High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting Enzyme
T. J. Esparza, N. P. Martin, G. P. Anderson…·D. L. Brody
This study identifies nanobodies that block SARS-CoV-2 spike protein interaction with ACE2, showing high affinity and stability after nebulization.
DOI 10.1038/s41598-020-79036-0